Copyright © 2024 Swire Pacific Limited. All rights reserved.
Cookies and Privacy: We use cookies to enhance your user experience on our website. Please indicate your cookie preference. For more information, please read our Cookie Policy and Privacy Notice.
Swire Pacific Limited (Swire Pacific or the Company) announced that it has completed the transaction to increase its stake in DeltaHealth China Limited (DeltaHealth). Swire Pacific initially made an associate investment in DeltaHealth in 2021 and signed definitive agreements to increase its stake in March 2024. This latest development marks the Company’s first time as the major shareholder in a healthcare business and aligns with Swire Pacific’s strategy of being a long-term owner and operator of healthcare services.
DeltaHealth comprises a cardiovascular-focused hospital, Shanghai DeltaHealth Hospital, and an outpatient clinic, DeltaWest Clinic, also in Shanghai. DeltaHealth has built up strong core capabilities in cardiovascular care. Shanghai DeltaHealth Hospital ranked first among private hospitals and within the top ten among all hospitals (including public hospitals) in Shanghai in terms of cardiovascular surgery volume in 2023. Aside from cardiovascular care, DeltaHealth has also recently expanded into thoracic surgery and oncology.